Diametric Capital »

Krystal Biotech shares owned by Diametric Capital

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $309k 830 371.67

More positions owned by Diametric Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Precigen (PGEN)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Fulgent Genetics (FLGT)
Ishares Tr Msci Eafe Etf (EFA)
A2z Cust2mate Solutions Corp (AZ)
Uniqure Nv SHS (QURE)
Liquidia Corporation Com New (LQDA)
Almonty Inds Com New (ALM)
Golar Lng SHS (GLNG)
Calumet (CLMT)
Abivax Sa Sponsored Ads (ABVX)
Digital Realty Trust (DLR)
Telephone & Data Sys Com New (TDS)
MGM Resorts International. (MGM)

View all positions for Diametric Capital

Top funds holding Krystal Biotech

FMR
BlackRock
venBio Select Advisor
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Soleus Capital Management
Capital World Investors
Vestor Capital Corp
Geode Capital Management
Hood River Capital Management
Redmile Group
William Blair Investment Management
T. Rowe Price Associates
Frazier Life Sciences Management

View all funds holding Krystal Biotech